Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1996
03/28/1996WO1996008966A1 Regulation of wound healing by nitric oxide
03/28/1996DE4436127A1 Use of benzoic or pyridine:carboxylic acid or amide cpds.
03/28/1996DE4435368A1 Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann The use of aromatase inhibitors for the manufacture of a medicament for treating a relative androgen deficiency in men
03/28/1996DE4434312A1 Antimycotic cosmetic and dermatological compsns.
03/28/1996CA2202526A1 Therapeutic and prophylactic agent for nervous disturbances
03/28/1996CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
03/28/1996CA2200755A1 Compositions and methods for the control of smoking
03/28/1996CA2200722A1 Aromatic ethers derived from indols such as 5ht1-like ligands
03/28/1996CA2200611A1 Cancer treatment by expression of differentiation factor receptor
03/28/1996CA2200571A1 Dna photocleavage using texaphryns
03/28/1996CA2200570A1 Use of muramyl peptide compounds
03/28/1996CA2200561A1 Compositions and methods for treating mast-cell inflammatory conditions
03/28/1996CA2200472A1 Novel heterocyclic derivatives, method of prodution thereof and pharmaceutical use thereof
03/28/1996CA2200451A1 Methods of inhibiting endometrial mitoses
03/28/1996CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods
03/28/1996CA2200443A1 Bicyclic carboxamides as 5-ht1a antagonists
03/28/1996CA2200205A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
03/28/1996CA2200204A1 Benzothiophene compounds, compositions, and methods
03/28/1996CA2199727A1 Ribozyme treatment of diseases or conditions related to levels of plasma lipoprotein (a) ¬lp(a)| by inhibiting apolipoprotein (a) ¬apo(a)|
03/28/1996CA2197554A1 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence
03/28/1996CA2176968A1 Novel carbamate compounds and processes for preparing the same
03/28/1996CA2176383A1 Supramolecular-structure biodegradable polymeric assembly for drug delivery
03/28/1996CA2174968A1 Estramustine formulations with improved pharmaceutical properties
03/27/1996EP0703239A1 Aminomethylphosphonic and aminomethylphosphinic acids derivatives and their use in the treatment of degenerative articular diseases
03/27/1996EP0703232A2 2,3-Dihydro-1H-isoindole derivates, a process for their preparation and their use as serotonin reuptake inhibitors
03/27/1996EP0703231A1 2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome
03/27/1996EP0703229A2 Process for the preparation of (R)-3-amino-5-methoxychroman
03/27/1996EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them
03/27/1996EP0703221A1 5 alpha-reductase Inhibitors
03/27/1996EP0703218A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
03/27/1996EP0702962A2 Preparations for inhibiting mammalian breast carcinoma with tamoxifen and analogs thereof, and certain naphthyl compounds
03/27/1996EP0702961A2 Compositions for minimizing the uterotrophic effect of tamoxifen and its analogs
03/27/1996EP0702954A2 Calcium dietary supplement
03/27/1996EP0702953A2 Dosage form comprising alpha-lipoic acid or solid salts thereof with improved bioavailability
03/27/1996EP0702951A1 Use of a NO-synthetase inhibitor as medicament for reducing alcohol consumption or for preventing excessive alcohol consumption
03/27/1996EP0702950A1 Use of fatty acids against skin superinfections
03/27/1996EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound
03/27/1996EP0702716A1 Ribozyme gene therapy for hiv infection and aids
03/27/1996EP0702699A1 Novel heparin-like sulfated polysaccharides
03/27/1996EP0702688A1 Antiparasitic agents
03/27/1996EP0702683A1 06-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
03/27/1996EP0702681A1 Spiro-substituted azacycles as neurokinin antagonists
03/27/1996EP0702680A1 2-oxo-1,2,3,4-tetrahydroquinoline derivatives
03/27/1996EP0702679A1 Process for the isolation of lovastatin
03/27/1996EP0702678A1 Aniline derivatives
03/27/1996EP0702673A1 Benz(b)azepine-2,5-diones useful in the treatment of neurodegenerative disorders
03/27/1996EP0702672A1 New active compounds
03/27/1996EP0702671A1 Bicyclic fibrinogen antagonists
03/27/1996EP0702669A1 Novel antiviral agents
03/27/1996EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
03/27/1996EP0702557A1 Therapeutic inhibitor of vascular smooth muscle cells
03/27/1996EP0702556A1 (phospho)lipids for combatting hepatitis b virus infection
03/27/1996EP0702555A1 Pyrazolopyrimidinones for the treatment of impotence
03/27/1996EP0702554A1 Use of an mhc class i suppressor drug for the treatment of autoimmune diseases and transplantation rejection
03/27/1996EP0702553A1 Water soluble non-immunogenic polyamide cross-linking agents
03/27/1996EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions
03/27/1996EP0702518A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
03/27/1996EP0702516A1 Genetic immunization with cationic lipids
03/27/1996EP0662836A4 Germicidal detergent-iodine compositions having reduced detergent content.
03/27/1996EP0651747B1 Carbostyryl derivatives
03/27/1996EP0646005A4 Methods for treating arteriosclerosis.
03/27/1996EP0608404B1 ANDROST-4-ENO[4,5-b]PYRROLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
03/27/1996EP0605543B1 Composition for external skin care
03/27/1996EP0548250B1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
03/27/1996EP0509036B1 Optically pure r(-) albuterol for treating asthma
03/27/1996EP0495053B1 New linker for bioactive agents
03/27/1996EP0473687B1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester
03/27/1996EP0448644B1 Transdermal estrogen/progestin dosage unit and system.
03/27/1996EP0414772B1 Method for treating acne
03/27/1996EP0262125B1 AICA riboside for the prophylactic treatment of diseases with restricted blood flow.
03/27/1996CN1119458A Nucleic acid pharmaceuticals
03/27/1996CN1119440A 2,6-diaminopurine derivatives
03/27/1996CN1119434A Phenoxyphenylacetic acid derivatives
03/27/1996CN1119191A 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
03/27/1996CN1119190A Process for producing sugar ester matter containing gangliosides as major matter
03/27/1996CN1119189A New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
03/27/1996CN1119187A oxalylamino-benzofuran- and benzothienyl-derivatives
03/27/1996CN1119183A Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
03/27/1996CN1119180A Semiantigen compound, synthesizing process and use thereof
03/27/1996CN1119102A Soluble powder for treating fowl disease
03/27/1996CN1119101A Thieno (1,5) benzodiazepine use
03/27/1996CN1119100A Preparation of pharmaceutical treating imbalance of memory and recognition with tri-cyclic compound
03/27/1996CN1119099A Method for preparing pharmacologically active CNS composition
03/27/1996CN1031404C Process for production of substituted azole
03/27/1996CN1031403C Process for preparation of hydroxyalkylfuranyl derivatives
03/27/1996CA2159034A1 Method of minimizing hepatic reperfusion injury
03/27/1996CA2158811A1 Calcium dietary supplement
03/26/1996US5502255 Substituted guanidines having high binding to the sigma receptor and the use thereof
03/26/1996US5502237 1-aryloxy-3-alkylamino-2-propanol-nitrate esters, the use thereof and corresponding pharmaceutical composition
03/26/1996US5502224 Antitumor agents
03/26/1996US5502216 Anticholesterol
03/26/1996US5502210 1H-isoindole-1,3-dione compounds
03/26/1996US5502209 Benzopyrancarboxamide derivatives, salts thereof, process for the preparation of same and use thereof
03/26/1996US5502203 Certain 6,7-dihydro-3(2-nitrophenyl)-1,2-benzisoxazol-4(5H)-ones as intermediates
03/26/1996US5502198 α-aryl or heteroaryl-substituted amide ester ACAT inhibitors
03/26/1996US5502193 2-substituted tertiary carbinol derivatives of 1,5-iminosugars
03/26/1996US5502183 Steroid intermediates and processes for their preparation
03/26/1996US5502177 Pyrimidine derivatives for labeled binding partners
03/26/1996US5502094 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
03/26/1996US5502080 Immune system disorders, fenfluramine, phentermine
1 ... 6931 6932 6933 6934 6935 6936 6937 6938 6939 6940 6941 6942 6943 6944 6945 6946 6947 6948 6949 6950 6951 ... 7860